Skip to main content

Stay up to date with our latest news.

Smiling woman patient with healthcare worker
Chembio

QUALIGEN DIAGNOSTICS ANNOUNCE AGREEMENT WITH AFAXYS GPO TO EXPAND ACCESS TO FASTPACK® IP QUANTITATIVE hCG TESTING IN WOMEN’S HEALTH

QUALIGEN DIAGNOSTICS ANNOUNCE AGREEMENT WITH AFAXYS GPO TO EXPAND ACCESS TO FASTPACK® IP QUANTITATIVE hCG…
Typhoid bacteria background
Chembio

CHEMBIO RECEIVES $1.8 MILLION CARB-X GRANT TO DEVELOP A RAPID DIAGNOSTIC TEST FOR TYPHOID FEVER

CHEMBIO DIAGNOSTIC SYSTEMS, INC., A BIOSYNEX SUBSIDIARY, RECEIVES $1.8 MILLION CARB-X GRANT TO DEVELOP A…
Chembio

CHEMBIO ANNOUNCES DUAL FDA SUBMISSION OF DPP® SYPHILIS TnT ASSAY FOLLOWING BREAKTHROUGH DEVICE DESIGNATION

CHEMBIO DIAGNOSTIC SYSTESMS INC., A SUBSIDIARY OF BIOSYNEX, ANNOUNCES DUAL FDA SUBMISSION OF DPP® SYPHILIS…
ABOUT US

Real-Time Answers. Real-Life Impact.

Advanced Rapid Diagnostics for Modern Healthcare

Chembio develops and manufactures rapid diagnostic solutions that bring reliable infectious disease testing closer to the patient. For more than three decades, we’ve partnered with healthcare providers, public health organizations and global partners to expand access to point-of-care diagnostics.

Learn More

We are looking for talented, dedicated people wishing to contribute to our common vision of enhancing the health and well being of people worldwide.

Subscribe to the Chembio Mailing List